Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Silgan Holdings
SLGN
$4.51B
| $5.62M | 0.01% |
189,543
+167,676
| +767% | +$4.62M |
|
1652
LCI Industries
LCII
$2.55B
| $5.6M | 0.01% |
72,857
-38,366
| -34% | -$3.03M |
|
1653
CALL
Keurig Dr Pepper
KDP
$43.3B
| $5.59M | 0.01% |
+200,000
| New | +$5.4M |
|
1654
Agilysys
AGYS
$3.23B
| $5.58M | 0.01% |
263,350
+194,974
| +285% | +$3.6M |
|
1655
Lindblad Expeditions
LIND
$2.08B
| $5.57M | 0.01% |
+365,250
| New | +$4.97M |
|
1656
Vanguard FTSE Europe ETF
VGK
$31.3B
| $5.57M | 0.01% |
103,850
+92,396
| +807% | +$4.83M |
|
1657
Gentherm
THRM
$1.23B
| $5.56M | 0.01% |
150,720
-121,004
| -45% | -$4.93M |
|
1658
Goodyear
GT
$1.78B
| $5.55M | 0.01% |
305,904
-1,885,051
| -86% | -$36.7M |
|
1659
iShares MSCI EAFE ETF
EFA
$80.4B
| $5.55M | 0.01% |
85,520
+76,679
| +867% | +$4.83M |
|
1660
PUT
American Airlines Group
AAL
$9.23B
| $5.54M | 0.01% |
174,400
+58,500
| +50% | +$1.97M |
|
|
LCI
1661
DELISTED
Lannett Company, Inc.
LCI
| $5.53M | 0.01% |
175,787
+150,333
| +591% | +$4.83M |
|
|
TPH
1662
DELISTED
Tri Pointe Homes
TPH
| $5.53M | 0.01% |
437,181
+175,725
| +67% | +$2.24M |
|
|
AMAG
1663
DELISTED
AMAG Pharmaceuticals
AMAG
| $5.52M | 0.01% |
428,865
+36,835
| +9% | +$549K |
|
1664
PUT
ScottsMiracle-Gro
SMG
$3.65B
| $5.5M | 0.01% |
+70,000
| New | +$5.28M |
|
|
NCOM
1665
DELISTED
National Commerce Corporation
NCOM
| $5.49M | 0.01% |
+140,049
| New | +$5.71M |
|
1666
iShares MSCI Japan ETF
EWJ
$22.6B
| $5.49M | 0.01% |
100,336
-157,717
| -61% | -$8.49M |
|
|
POLY
1667
DELISTED
Plantronics, Inc.
POLY
| $5.46M | 0.01% |
118,482
-162,242
| -58% | -$7.08M |
|
1668
The GEO Group
GEO
$4.23B
| $5.45M | 0.01% |
283,780
+19,898
| +8% | +$427K |
|
|
BRKL
1669
DELISTED
Brookline Bancorp
BRKL
| $5.44M | 0.01% |
377,761
+332,245
| +730% | +$4.98M |
|
|
HMHC
1670
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $5.43M | 0.01% |
747,125
+51,726
| +7% | +$465K |
|
1671
PACCAR
PCAR
$68B
| $5.43M | 0.01% |
119,541
-386,292
| -76% | -$16.8M |
|
1672
PUT
DaVita
DVA
$11.3B
| $5.43M | 0.01% |
+100,000
| New | +$5.53M |
|
1673
LeMaitre Vascular
LMAT
$1.81B
| $5.43M | 0.01% |
+175,049
| New | +$4.67M |
|
|
UROV
1674
DELISTED
Urovant Sciences Ltd.
UROV
| $5.43M | 0.01% |
539,889
+136,239
| +34% | +$1.4M |
|
|
AAT
1675
American Assets Trust
AAT
$1.42B
| $5.42M | 0.01% |
118,221
+70,284
| +147% | +$3.04M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.